Niraparib + Dostarlimab + RT in Pancreatic Cancer

NCT04409002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Metastatic Pancreatic Cancer

Interventions

DRUG: Niraparib
DRUG: Dostarlimab
RADIATION: Radiation

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]